ClinConnect ClinConnect Logo
Search / Trial NCT03465683

Transmission of ESBL-producing Enterobacteriaceae

Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Mar 13, 2018

Trial Information

Current as of July 10, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how certain bacteria, called ESBL-producing Enterobacteriaceae, spread in hospitals and cause infections that patients might get while being treated. The researchers want to understand both the bacteria themselves and the tiny pieces of DNA that help these bacteria spread. This information will help identify where these infections come from and how to prevent them.

To participate in this study, you need to be over 1 year old and have tested positive for these bacteria during routine medical tests at the University Hospital Basle between January 1 and December 31, 2019. If you meet these criteria, you may be eligible to join the study. Participants can expect to contribute to important research that could improve hospital safety and patient care. This study is currently recruiting participants of all genders.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • aged above 1 year
  • proven ESBL-PE carriage from any specimens obtained by routine clinical practice out and inpatients from University Hospital Basle from January 1st until December 31st 2019
  • Exclusion Criteria:
  • not meeting inclusion criteria

About University Hospital, Basel, Switzerland

The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.

Locations

Basel, , Switzerland

Patients applied

0 patients applied

Trial Officials

Sarah Tschudin-Sutter, PD MD

Principal Investigator

Division of Infectious Disease and Hopital Epidemiology, University Hospital Basle

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials